| IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma RA Cairns, J Iqbal, F Lemonnier, C Kucuk, L De Leval, JP Jais, M Parrens, ... Blood, The Journal of the American Society of Hematology 119 (8), 1901-1903, 2012 | 572 | 2012 |
| Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters F Lemonnier, L Couronné, M Parrens, JP Jaïs, M Travert, L Lamant, ... Blood, The Journal of the American Society of Hematology 120 (7), 1466-1469, 2012 | 503 | 2012 |
| Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas D Vallois, MPD Dobay, RD Morin, F Lemonnier, E Missiaglia, M Juilland, ... Blood, The Journal of the American Society of Hematology 128 (11), 1490-1502, 2016 | 319 | 2016 |
| Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study E Bachy, JF Seymour, P Feugier, F Offner, A López-Guillermo, D Belada, ... Journal of Clinical Oncology 37 (31), 2815-2824, 2019 | 245 | 2019 |
| Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma TB Heavican, A Bouska, J Yu, W Lone, C Amador, Q Gong, W Zhang, Y Li, ... Blood, The Journal of the American Society of Hematology 133 (15), 1664-1676, 2019 | 244 | 2019 |
| Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2 S Inoue, WY Li, A Tseng, I Beerman, AJ Elia, SC Bendall, F Lemonnier, ... Cancer cell 30 (2), 337-348, 2016 | 222 | 2016 |
| Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin MP Dobay, F Lemonnier, E Missiaglia, C Bastard, D Vallois, JP Jais, ... Haematologica 102 (4), e148, 2017 | 206 | 2017 |
| Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma F Lemonnier, J Dupuis, P Sujobert, O Tournillhac, M Cheminant, ... Blood, The Journal of the American Society of Hematology 132 (21), 2305-2309, 2018 | 169 | 2018 |
| Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL C Laurent, A Nicolae, C Laurent, F Le Bras, C Haioun, V Fataccioli, ... Blood, The Journal of the American Society of Hematology 135 (5), 360-370, 2020 | 126 | 2020 |
| The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development F Lemonnier, RA Cairns, S Inoue, WY Li, A Dupuy, S Broutin, N Martin, ... Proceedings of the National Academy of Sciences 113 (52), 15084-15089, 2016 | 121 | 2016 |
| Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma F Jardin, A Pujals, L Pelletier, E Bohers, V Camus, S Mareschal, S Dubois, ... American journal of hematology 91 (9), 923-930, 2016 | 113 | 2016 |
| The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations J Steinhilber, M Mederake, I Bonzheim, E Serinsöz-Linke, I Müller, ... Modern Pathology 32 (8), 1123-1134, 2019 | 68 | 2019 |
| Roles of IDH1/2 and TET2 mutations in myeloid disorders S Inoue, F Lemonnier, TW Mak International journal of hematology 103, 627-633, 2016 | 63 | 2016 |
| Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma. M Cheminant, J Bruneau, O Kosmider, F Lefrere, R Delarue, P Gaulard, ... British journal of haematology 168 (6), 2015 | 62 | 2015 |
| Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma F Lemonnier, V Safar, A Beldi-Ferchiou, AS Cottereau, E Bachy, ... Blood Advances 5 (2), 539-548, 2021 | 49 | 2021 |
| GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-κB-dependent mechanism L Mondragón, R Mhaidly, GM De Donatis, M Tosolini, P Dao, AR Martin, ... Cancer Cell 36 (3), 268-287. e10, 2019 | 49 | 2019 |
| Response to 5‐azacytidine in a patient with TET2‐mutated angioimmunoblastic T‐cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV … C Saillard, H Guermouche, C Derrieux, J Bruneau, L Frenzel, L Couronne, ... Hematological Oncology 35 (4), 864-868, 2017 | 45 | 2017 |
| Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome L Veloza, D Cavalieri, E Missiaglia, A Ledoux-Pilon, B Bisig, B Pereira, ... Haematologica 108 (1), 181, 2023 | 43 | 2023 |
| Treatment with hypomethylating agent 5-azacytidine induces sustained response in angioimmunoblastic T cell lymphomas R Delarue, J Dupuis, P Sujobert, S Barbieux, A Marçais, O Tournilhac, ... Blood 128 (22), 4164, 2016 | 39 | 2016 |
| Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial R Houot, E Bachy, G Cartron, FX Gros, F Morschhauser, L Oberic, ... Nature Medicine 29 (10), 2593-2601, 2023 | 36 | 2023 |
